91ֿ

Department of Chemistry and Biochemistry

In 1901, the 16 Major League Baseball teams produced 455 home runs. Players were discouraged from attempting it. Nearly 120 years later, players couldn’t seem to help themselves, and MLB smashed all previous records. More homers might mean more exciting games, but some people question why the spike happened. A 91ֿ chemist thinks he has some clues about this unusual surge in home runs.

Students studying in a classroom

The “C” in “college” might as well stand for “cramming.”
Studies show students are notoriously bad at adopting and adhering consistently to high-impact study habits that help them retain knowledge long-term.
Researchers and faculty at 91ֿ, however, are collaborating on a new project to put a modern technological twist on a tried-and-true study tactic.

Materials Science Graduate Program: Graduate Education on Soft Matter Science
Mietek Jaroniec, Ph.D., professor in the Department of Chemistry and Biochemistry of 91ֿ’s College of Arts and Sciences, was appointed to the editorial board of the journal Science Advances.

Division of Research & Economic Development
Mietek Jaroniec, Ph.D., professor in the Department of Chemistry and Biochemistry of 91ֿ’s College of Arts and Sciences, was appointed to the editorial board of the journal Science Advances.

91ֿ professor Hanbin Mao (middle) co-authored a paper with graduate students Sagun Jonchhe (left) and Prakash Shrestha (right) on the genetic factors influencing the formation of cancer cells.

According to the American Cancer Society, there will be an estimated 1,688,780 new cancer cases diagnosed and 600,920 cancer deaths in the U.S. in 2017. These numbers are stark and sobering, and worse yet, we still do not know exactly why cancer develops in its victims or how to stop it. An online publication in Nature Nanotechnology this week by 91ֿ researchers and their colleagues at Kyoto University in Japan, however, may offer new understanding about what turns good cells bad.

According to the American Cancer Society, there will be an estimated 1,688,780 new cancer cases diagnosed and 600,920 cancer deaths in the U.S. in 2017.

These numbers are stark and sobering, and worse yet, we still do not know exactly why cancer develops in its victims or how to stop it.

An online publication in Nature Nanotechnology this week by 91ֿ researchers and their colleagues at Kyoto University in Japan, however, may offer new understanding about what turns good cells bad.